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Abstract
Purpose To review the relative cost-effectiveness of allografts and autografts in reconstruction of the posterior cruciate 
ligament.
Methods Systematic review and cost-effectiveness analysis.
Results The available evidence does not show any significant difference in clinical effectiveness between autografts and 
allografts. Given that, only a cost analysis is provided, which shows that allografts are more costly.
Conclusion Given the lack of any benefit of allografts over autografts, autografts should be preferred on cost grounds, if 
available. However, there may be situations where an allograft is indicated, for example, in multiple ligament reconstructions.
Level of evidence IV.
Keywords Posterior cruciate ligament · Reconstruction · Cost analysis · Clinical effectiveness
Abbreviations
PCL  Posterior cruciate ligament
OA  Osteoarthritis
ACL  Anterior cruciate ligament
IKDC  International knee documentation committee
RCTs  Randomised controlled trials
CCT  Controlled clinical trial
Introduction
Pache et al. [19] provide a useful overview of the posterior 
cruciate ligament (PCL), noting that its function is to stop 
the femur from sliding too far forward on the tibia. Injuries 
occur during sports such as soccer and rugby, and also in 
road traffic accidents, when the flexed knee hits the dash-
board and the tibia is displaced backwards.
PCL ruptures are much less common than ACL ruptures 
(about 10% of ACL numbers) and allografts are commonly 
used, partly because PCL rupture may be part of a multi-
ligament problem, when allografts may become necessary 
due to a lack of graft availability. Such situations do need 
to be considered when assessing these results, but for the 
remainder of this report it is assumed that the PCL is an iso-
lated injury, that both autografts and allografts are available, 
and that a choice can be made between them.
The PCL has much more capacity for healing than the 
ACL, and many PCL ruptures are treated conservatively, 
especially if the rupture is partial. Repairs can be a single 
bundle of the antero-lateral bundle only, or double bundle 
of both. Pache et al. [19] prefer double-bundle repairs, not-
ing that previous single-bundle repair studies reported that 
though results were mostly good, many patients were left 
with posterior laxity which was associated with osteoar-
thritis (OA) in later years. An earlier systematic review by 
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Chahla et al. [4] used data from 441 patients in 11 studies 
(mostly not achieving good quality scores, only three were 
RCTs) to compare the results of double- and single-bundle 
repairs. Both methods improved knee stability and patient 
outcomes, but double bundles gave better posterior stability 
and IKDC scores.
The original aim of the cost-effectiveness analysis was 
to determine whether an allograft or an autograft is the 
more cost-effective option for patients requiring a PCL 
reconstruction. Isolated PCL injuries often respond to con-
servative care including physiotherapy, but some cases do 
cause problems despite conservative care and require sur-
gery. The starting point of this analysis was that it had been 
decided that surgery is required, so conservative care was 
not included in the economic model.
Materials and methods
A systematic review was carried out, looking first for good-
quality, recent systematic reviews.
Fuller details of methods are given in the full report which 
will be available at https ://www.esska .org, but in brief;
• The databases Ovid Medline, Ovid Embase, Web of 
Science and the Cochrane Library for articles published 
from the year 2000 until February 15th 2018. The Med-
line search strategy and the numbers of records obtained 
are shown in Appendix 1 of the full report on the ESSKA 
website.
• Titles and abstracts of retrieved studies were screened 
by two people, with full papers obtained if inclusion or 
exclusion was uncertain from the abstract
• Standard systematic review methods were used with 
quality assessment of included studies using standard 
checklists for both reviews and primary studies, and 
checking of data extractions by a second reviewer
For economics analysis, a decision tree model was devel-
oped within Microsoft Excel® and was considered the most 
appropriate choice as reconstruction is usually successful 
and most patients return to a functioning knee after recon-
structive surgery. The starting point for the economic model 
is at the point where the decision is made to do PCL recon-
struction. The clinical pathways were developed using infor-
mation from the published literature and clinical experience.
However, cost-effectiveness analysis is only worthwhile 
if there are differences in clinical effectiveness. If there are 
none reported, one cannot generate utility data and QALYs. 
A model for analysis was developed but given the paucity 
of evidence comparing allografts and autografts, and the 
lack of any significant differences between them in the 
available studies and analyses, no modelling analyses were 
undertaken. Therefore, a simple cost analysis is presented 
comparing the cost of allografts versus autografts for PCL 
reconstruction. It is assumed that patients have isolated PCL 
injuries.
Resource use and costs
All unit costs reported in Table 1 are presented in pounds 
sterling (£) in 2016/17 prices. The cost of the allograft 
(£2400) was obtained from the NHS Tissue Services price 
list for 2018/19 and was based on an average price of a tibi-
alis posterior tendon [16]. There is no cost for the graft in 
the HS autograft arm, except a little extra theatre time (but 
the procedure code will not change, so the hospital charge 
will not vary). Costs include that of the procedure, three 
consultant-led follow-up clinics, eight physiotherapy ses-
sions and the cost of analgesics (paracetamol and ibuprofen). 
We have assumed that a second or third PCL revision would 
cost the same as a first reconstruction.
It was assumed that 0.3% of all reconstructions will get 
infections based on a recent ACL study [24]. The cost of 
infections was obtained from the Genuario et al. [8] paper 
in US $ in 2010 prices. These costs were converted into UK 
£ in 2017 prices using the World Bank gross domestic prod-
uct deflators [25] and the purchasing power parity measures 
[17]. The cost of treatment for an infection included the cost 
of requiring debridement, irrigation, and antibiotics started 
intravenously with 1-week hospital admission, and then con-
tinued for a further 5 weeks [2].
Results
A systematic review by Hudgens et al. [10] included 19 stud-
ies, of which 5 were on allografts, 12 on autografts and 2 
[1, 23] compared the grafts. Hudgens et al. summarised the 
advantages of allografts as: shorter operation time, avoid-
ance of donor site morbidity, and a range of graft length and 
thickness. Disadvantages include deleterious effects on graft 
strength from sterilisation methods, costs, problems with 
availability, and a theoretical risk of disease transmission. 
Some of these hazards are now historical. Disadvantages of 
autografts included graft size limitations, and the effects of 
harvesting—increased theatre time, graft site infection, and 
donor site pain. Hudgens et al. note the scarcity of com-
parative data but conclude that both grafts give satisfactory 
results.
Tian et al. [22] provide a meta-analysis of autograft 
and allografts in PCL reconstruction but include only five 
studies, the RCT by Li et al. [12], and CCTs by Ahn et al. 
[1], Li et al. [11], Sun et al. [21] and Wang et al. [23], 
some of which we would exclude. Ahn et al. [1] had only 
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18 patients in each group. Tian et al conclude that there 
is insufficient evidence to say whether autografts or allo-
grafts are better.
Systematic reviews that were identified in the searches 
were used as a source of primary studies. Two studies com-
pared allografts and autografts, Wang et al. [23] and Ahn 
et al. [1]. Both had weaknesses. Wang et al. [23] randomised 
patients by day of admission, and lack of availability of allo-
grafts resulted in unequal numbers in arms, with 23 allo-
grafts (14 Achilles, 9 anterior tibial) and 32 autografts (16 
quadriceps, 16 hamstring). The Ahn et al. controlled clini-
cal trial (CCT) compared double loop hamstring autografts 
used in 1997–1999 with Achilles tendon allografts used in 
1999–2000. Six prospective studies of allografts in posterior 
cruciate ligament (PCL) reconstruction [13–15, 20, 26, 27] 
were included. Two studies [12, 21] were excluded because 
grafts were irradiated. There was a range of study designs, 
with two RCTs of allograft options, one RCT comparing 
allografts and autografts, two CCTs and four single-arm 
before and after studies. Study characteristics and baseline 
characteristics of the participants are summarised in the Sup-
plementary file. The risk of selection bias in the RCTs was 
unclear, and was high in the CCT. The quality of the single-
arm before and after studies was fair in two studies [14, 20] 
and poor in two studies [15, 27]. The Cooper et al. [5] case 
series included patients receiving allografts for combined 
reconstructions and autografts for isolated PCL reconstruc-
tions, but 85% of patients had combined reconstructions so 
in effect it is a case series of only six patients, so of limited 
value for this analysis. The overall quality and details of each 
study are reported in Table 2 below and the Supplementary 
table. Not all are relevant to the primary question.
Failure and survival
None of the studies reported allograft failure rates or sur-
vival of the allograft. Spiridonov et al. [20] reported a rate 
of implant removal of 7.7% at a mean of 2.5 years follow-up. 
Li et al. [13] stated that no participants required additional 
surgery because of recurrent or residual symptoms.
Functional outcomes
Six studies reported the Lysholm knee score [14, 15, 23, 
26, 27]. In the CCT by Wang et al. [23] (high risk of selec-
tion bias), there was no statistically significant difference 
between the allograft group and the autograft group at end-
point (Table 2). All other studies demonstrated a statistically 
significant improvement in Lysholm score at endpoint. Sam-
ple sizes were small and no studies were of low risk of bias/
good quality; Lim et al. [14] was of fair quality.
Four studies [13, 14, 23, 26] reported the Tegner score 
(Table 3). There was no statistically significant difference 
between allografts and autografts in the Wang et al. study. 
All other studies found a statistically significant improve-
ment in Tegner score at follow-up, although no studies were 
of low risk of bias/good quality and sample sizes were small.
Four studies assessed the IKDC subjective score as shown 
in Table 4. In the Yoon et al. [26] and Spiridonov et al. [19] 
studies that compared endpoint results with baseline, for 
Table 1  Resource use and costs for PCL reconstruction
Resource use Unit cost (£) Source
Graft type
Allograft £2400 Tissue bank [16]
Procedure
Intermediate knee procedures for non-trauma, 19 years and over (HRG code: HN24C) £1642 NHS reference costs 2015–2016 [9]
Other related costs
Three consultant-led outpatient follow-up attendance (HRG code: WF01A) £336 NHS reference costs 2015–2016 [9]
Eight hospital physiotherapy sessions (30 min) £132 UCHSC 2017 [6]
Paracetamol (two tablets twice a day per year) £23.21 BNF 2016−2017 [3]
Ibuprofen (one tablet a day per year) £12.47 BNF 2016–2017
Total costs
Allograft £4395
HS autograft £2145
BPTB autograft £2145
Infection
Infections £7,761 Genuario et al. [8]
Conservative care
One consultant-led outpatient follow-up attendance (HRG code: WF01A) £112 NHS reference costs 2015–2016 [9]
Eight hospital physiotherapy sessions (30 min) £132 UCHSC 2016 [7]
1813Knee Surgery, Sports Traumatology, Arthroscopy (2019) 27:1810–1816 
1 3
allografts only, statistically significant improvements were 
seen. Cooper et al. [13] found similar results with autografts 
and allografts.
Quality of life
No studies of PCL reported quality of life.
Adverse events
Of the seven studies, only three reported any specific com-
plications or adverse events and rates were generally low. 
Yoon et al. [26] reported post-operative limited range of 
motion in 4% and 7% of participants in the single-bundle 
allograft and double-bundle allograft groups, respectively. 
Wang et al. [13] reported one complication (organism iso-
lated from wound but no clinical infection) in the allograft 
group and seven (21.9%; two infections, four donor site 
pain, one reflex sympathetic dystrophy) in their autograft 
group. Min et al. [13] reported arthrofibrosis in one case 
and irritation leading to tibial screw removal in four of their 
21 allograft cases. Li et al. [13] reported no major neuro-
logic, vascular, or wound complications. Spiridonov et al. 
[20] reported no intra-operative neurovascular injuries, deep 
vein thrombosis or infections, and Lim et al. [14] reported no 
complications. Yoon et al. [27] did not report adverse events.
Cost analysis
Table 5 shows the base-case discounted cost results. Having 
an allograft as a primary ACL reconstruction is more costly 
(£2455 more) than having a HS autograft as a primary ACL 
reconstruction. The main cost driver for this result was the 
cost of the graft.
Table 2  Lysholm knee score, 
PCL reconstruction
a P value between baseline and 24 months after surgery, data presented are for final follow-up
b Rates different in the abstract, which were 53 (SD 5.3), range 34–68 pre-operatively and 83.5 (SD 13), 
range 61–97 at follow-up of mean 49.2 months (range 25–73). ROB risk of bias
Lysholm Knee score at final 
endpoint, mean (SD) unless 
stated
P value
Ahn [1] unclear ROB Allograft group n = 18 Autograft group n = 18  < 0.01
Baseline 68.6 68.2
Change at endpoint + 17.2 + 21.9
Li [13] Unclear ROB Single-bundle allograft, n = 22 Double-bundle allograft, n = 24
Baseline value 63.1 (3.8) 64.6 (4.3) NA
Endpoint value 88.0 (4.2) 89.8 (3.8)
P value < 0.05a < 0.05a
Wang [23] high ROB Allograft group, n = 23 Autograft, n = 32
Endpoint value 92.3 (6.8) 87.8 (9.6) n.s
Yoon [26] unclear ROB Single-bundle allograft, n = 25 Double-bundle allograft, n = 28
Median (range)
 Baseline value 64 (41–73) 62 (43–71) NA
 Endpoint value 89 (71–99) 91 (76–100)
 P value < 0.001 < 0.001
Min [15] poor quality Allograft, n = 21
Mean (range)
 Baseline value 52.2 (42–66)b
 Endpoint value 78 (56–92)b
 P value < 0.001
Lim [14] fair quality Allograft, n = 22
Median (range)
 Baseline value 64 (50–75)
 Endpoint value 88 (82–96)
 P value < 0.001
Yoon [27] poor quality Allograft, n = 26
Baseline value 59.5
Endpoint value 91.8
P value < 0.05
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Discussion
Most studies cited in this review were observational stud-
ies, with only one relevant RCT, and two CCTs, most with 
only about 20 or so patients, and none being rated as hav-
ing a low risk of bias. The RCT by Wang et al. [23] was 
rated at high risk of bias, partly because of the method of 
randomisation (according to day of admission), and partly 
Table 3  Tegner scores, PCL 
reconstruction
a P value between baseline and 24 months after surgery, data presented are for final follow-up
b States mean, reviewer assumed this is median as per the other outcomes
Tegner score at final endpoint, mean (SD) unless stated P value
Li [13] unclear ROB Single-bundle allograft, n = 22 Double-bundle allograft, n = 24
Baseline value 3.1 (0.6) 3.3 (1.0) NA
Endpoint value 6.2 (0.9) 6.8 (1.2)
P value < 0.05a < 0.05a
Wang [23] high ROB Allograft group, n = 23 Autograft, n = 32
Endpoint value 4.70 (1.66) 4.73 (1.66) n.s
Yoon [26] unclear ROB Single-bundle allograft, n = 25 Double-bundle allograft, n = 28
Median (range)
 Baseline value 2 (1–3) 2 (1–3) NA
 Endpoint value 6 (4–7) 6 (4–7)
 P value < 0.001 < 0.001
Lim [14] fair quality Allograft, n = 22
Median (range)
 Baseline value 3 (2–5)
 Endpoint value 6 (3–9)b
 P value < 0.01
Table 4  IKDC subjective, PCL reconstruction
IKDC subjective at final endpoint, mean (SD) unless stated P value
Ahn [1] Autograft n = 18 Allograft n = 18
Final follow-up 16 normal, 2 abnormal 14 Normal, 4 abnormal n.s
Li [13] unclear ROB Single-bundle allograft, n = 22 Double-bundle allograft, n = 24
Endpoint value 65.5 (7.8) 71.6 (6.7) NA
Yoon [26] unclear ROB Single-bundle allograft, n = 25 Double-bundle allograft, n = 28
Median (range)
 Baseline value 40.2 (27.6–46.0) 39.1 (27.6–48.3) NA
 Endpoint value 79.3 (59.8–88.5) 81.7 (65.5–88.5)
 P value < 0.001 < 0.001
Spiridonov [20] fair quality Allograft, n = 39
 Baseline value 39.3 (18.8)
 Endpoint value 74.3 (23.1), n = 31
P value < 0.0001
Cooper [5] Allografts 25, autografts 16, but only 6 autografts in isolated PCLR
Baselines all severely 
abnormal based on 
stability
Average final score 75 (20–100) with slightly better scores with BPTB autografts than BPTB allografts (76 versus 
74, P < 0.05, but clinically not significant), but overall results are similar. But different graft thicknesses and 
mixture acute and chronic
Table 5  Base-case discounted results, PCL reconstruction
Procedure Total mean costs £ Incremental costs
HS autograft £2426 –
Allograft £4881 £2455
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because of problems with the supply of allografts, which 
were not always available. Some older trials were excluded 
because allografts were irradiated, sometimes with 2.5 
Mrad, sometimes with an unspecified dose. Most stud-
ies were of allografts only, sometimes comparing single 
bundle with double bundles. Clinical practice in our cen-
tre is that if a double-bundle PCL reconstruction is being 
done, allografts are more likely to be used, the view being 
that double-bundle PCL reconstruction would require two 
ligament autografts. However, from the comparative stud-
ies in this review, it appears that short-term results from 
small studies are similar for single bundle and double bun-
dles [13, 26]. The evidence of reduced posterior laxity in 
double-bundle reconstructions raises the possibility of a 
difference in long-term outcomes appearing over time but 
that is theoretical only and has no current evidence base, 
and so is not considered in this analysis.
Ahn et al. [1] summarised the advantages of using Achil-
les tendon allografts as decreased surgical time, absence 
of donor site morbidity, and bone to bone fixation, and the 
disadvantages are cost, longer time to heal, and possibly 
tendency to stretch. They considered the disadvantages of 
double-loop hamstring tendon autografts to be short length 
(10–11.5 cm) and harvesting time, and morbidity.
This analysis started from the decision to operate and 
surgical reconstruction was not compared with non-opera-
tive care. A study by Oweson et al. [18] examined the cost-
effectiveness of surgical reconstruction for isolated PCL 
injuries, looking at both single-bundle autograft and double-
bundle allograft, compared to non-surgical care (dynamic 
brace, 6 months of physiotherapy rehabilitation, with 2 ses-
sions a week, and independent training). They expressed 
cost-effectiveness in terms of cost per KOOS point. They 
considered that single-bundle autograft reconstruction was 
cost-effective compared to non-surgical care. Of interest to 
this review, they also compared double-bundle allograft to 
single-bundle autograft, noting the extra cost (allograft 4200 
euros plus some fixation costs) but failed to find convincing 
evidence that double bundle was sufficiently more effective 
to justify the extra costs.
In practice around half of PCL ruptures are part of multi-
ligament injuries where graft availability limits the choices 
of the surgeon, and the findings of this review may not apply.
Conclusion
The before and after evidence shows benefit from the use of 
allografts, but does not provide any evidence for their supe-
riority over autografts in isolated reconstruction of the PCL. 
Given the extra cost of allografts, they do not seem justified 
if autografts are available, and if there is no clinical reason 
to prefer an allograft. However, PCL injuries often occur as 
part of multi-ligament knee injuries, where availability of 
suitable autografts may be an issue.
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